ClinicalTrials.gov
public full text
Public Domain
The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome
Our hypothesis is that TA-65, a dietary supplement will help to reduce insulin resistance and plasma glucose in individuals classified with metabolic syndrome.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- TA-65 and Aging Associated Microvascular Dysfunction#1307268
- Physical Exercise in Patients With First Psychotic Episode#865024
- DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril#369914
- The impact of automated insulin delivery on glucose management in people with diabetes and advanced chronic kidney disease#319399
- Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial#842186
Record · ID 1246320
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive